Donna Frank

Donna Frank has extensive experience in the biopharmaceutical industry, holding various leadership roles at Ultragenyx from July 2019 to January 2024, including Executive Director for US Metabolic Bone Commercial Strategy and Launch Planning, as well as US Crysvita Commercial Field. Prior experience includes a Senior Manager position at Genentech in Commercial Training & Development, and a Senior Marketing Manager role at Amgen focused on Global Value and Access Marketing within Managed Markets. Donna Frank's early career features District Sales Manager positions at Boehringer Ingelheim and Andrx, where responsibilities included developing sales strategies and fostering customer relationships. Donna Frank holds a Bachelor of Science degree in Microbiology from both Indiana University Bloomington and the University of Wisconsin–Oshkosh.